Download Document

Dr. George A. Oyler
President & Founder
November 13, 2013
Company Model
SR
Therapeutics for
Biodefense Infectious
Disease & Regenerative
Medicine
Founded 2006
High-Performance
“Functional” Animal
& Aquacuture Feeds
Commodity-Scale
Algae Production
Founded 2009
Close partnership with Synaptic Research (SR) for
tailored biologics and functional foods to address the
needs of an aging nation and growing population.
November 13, 2013
Value Proposition
Premium Algae Pharmaceuticals:
• High-performance animal feed (farm animals)
• Animal feed health supplement for pets: healthy living
• Oral vaccines and therapeutics for humans and animals
Additional Income Streams:
• Environmental improvement
• Slow-release fertilizer
Future Potential Products:
• Bioenergy generation & biofuels
• Fine chemicals and specialty oils
• Cosmeceuticals: anti-aging skin formula
November 13, 2013
CGC Products Under Development
Premium Functional Animal Feeds (large-scale):
• Omega-3 or nutricentional enriched algae for aquaculture, cattle
feed
High-Performance Oral Vaccines (mid-scale):
• Recombinant anti-toxins in green algae
collaboration with Mayfield Lab (UCSD) for mouse feeding trial
Recombinant protein vaccines in diatoms:
• collaboration with Hildebrand Lab (UCSD); joint patent pending
Pipeline:
SR
Protein Engineering
Commodity-Scale
November 13, 2013
Integrated Algae for Functional Feeds
Algae
Production
Aquaculture
Production
Algae can be combined with animal
agriculture, anaerobic digestion, &
aquaculture as an integrated industry
November 13, 2013